The Clinical Research Team at Medicenna Therapeutics is responsible for designing, managing, and executing clinical trials to evaluate the safety and efficacy of the company's novel immunotherapies, including IL-2, IL-4, and IL-13 Superkines and Empowered Cytokines (ECs). Led by the Head Of Clinical Development, this team works closely with cross-functional departments to ensure adherence to regulatory standards and to advance the development of targeted treatments for cancers and immune-mediated diseases.